Are you Thaira Oweity, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileThaira Oweity, M.D. practices cytopathology in New York, NY. Medicare claims data shows Thaira provided 871 services to 636 patients. The services billed most often include microscopic genetic analysis of tumor, manual, evaluation of fine needle aspirate with interpretation and report, and evaluation of fine needle aspirate. The provider's National Provider Identifier (NPI) is 1124011861.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
550 1ST AVE 10 U
New York, NY 10016
Within Pathology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Autoimmune & Joints
Autopsy & Forensic
Blood & Metabolism
Blood Disorders
Cancer
Cervical & Gynecologic
Digestive
Digestive System
Endocrine
Genetics
Hormones
Immune System
Infections
Kidney
Liver
Metabolic & Routine Lab
Pregnancy & Fertility
Skin Cancer
Women's Health
Cytology & Screening
Autopsy & Forensic
Blood Tests
Cytology
Genetic & Molecular Tests
Genetics
Immune & Allergy Tests
Infection Testing
Infection Tests
Lab & Blood Tests
Pathology Review
Pregnancy & Fertility
Routine Lab Tests
Tissue Biopsy
871 services · 636 patients · 12 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Fine needle aspiration biopsy using ultrasound guidance, first growth | Procedure | 10005 |
65 | More often than most peers in Cytopathology |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Procedure | 10006 |
19 | Too few peers to compare |
| Fine needle aspiration biopsy, first growth | Procedure | 10021 |
17 | Too few peers to compare |
| Microscopic genetic analysis of tumor, manual | Lab test | 88360 |
163 | More than most peers in Cytopathology |
| Evaluation of fine needle aspirate with interpretation and report | Lab test | 88173 |
147 | More often than most peers in Cytopathology |
| Evaluation of fine needle aspirate | Lab test | 88172 |
144 | More often than most peers in Cytopathology |
| Pathology examination of tissue using a microscope, intermediate complexity | Lab test | 88305 |
135 | Less often than most peers in Cytopathology |
| Special stained specimen slides to examine tissue, each additional procedure | Lab test | 88341 |
54 | Less often than most peers in Cytopathology |
| Special stained specimen slides to examine tissue, initial procedure | Lab test | 88342 |
45 | Less often than most peers in Cytopathology |
| Surgical pathology consultation and report on referred slides prepared elsewhere | Lab test | 88321 |
45 | More often than most peers in Cytopathology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Thaira Oweity is a cytopathology in New York, NY. That is the designation recorded for this NPI in the federal registry.
NPI registry
Thaira Oweity is listed at 550 1St Ave 10 U, New York, NY 10016. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (212) 263-5687. Contact the office directly to confirm availability and scheduling.
NPI registry
Thaira Oweity's National Provider Identifier is 1124011861. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Thaira Oweity attended Other, graduating in 1990. This comes from the CMS National Downloadable File.
CMS public data
Thaira Oweity has 36 years experience. Calculated from a graduation year of 1990, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Thaira Oweity performs procedures including fine needle aspiration biopsy using ultrasound guidance, first growth, fine needle aspiration biopsy using ultrasound guidance, each additional growth and fine needle aspiration biopsy, first growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Thaira Oweity. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.
A GigHz company · Founder: Pouyan Golshani, MD